EUVIMED · CrossrefJournal
C&EN Global Enterprise
ISSN 2474-7408 · American Chemical Society (ACS)
Latest articles
Table of Contents
CAS announces 2026 Future Leaders
Memory Lane: From the steering committee to global researcher, professor, and mentor
ACS recognizes 2026 50-year members
Ads
Iran war will debilitate petrochemicals for the rest of 2026
Long-duration batteries are a winner in the AI boom
Merck to buy Terns in $6.7 billion deal
Lilly’s weight-loss pill wins FDA approval
April 7 Business Watch: Iran war hits Persian Gulf facilities; Trump throws tariffs on pharma
March 24 Business Watch: Helium capacity taken out in Qatar; Novartis to pay $2 billion for oncology small molecule
March 21 Business Watch: South Korea consolidation advances; drugmakers strike big deals
Classifieds
A future where the Women Chemists Committee is no longer necessary
Remastering local sections
Investing in tomorrow’s chemists—today
How do you study microplastics when they’re everywhere?
Editorial: Facts are in crisis. What are we going to do?
Enough is enough
Rethinking serotonin’s role in mental health
Can amylin weight-loss drugs compete in a world of GLP-1s?
Universities forge a bumpy new path on indirect research costs
Periodic Graphics: The chemistry of smoking foods
Opinion: Europe can’t ‘simplify’ itself out of a toxic-chemical health crisis
The hidden costs of chemistry
pHun time
Masthead
Data discovered in surprising places
Trump’s 2027 budget proposes deep cuts to science programs
Women and early-career researchers hit hardest by NIH grant cancellations
EUVIMED